ADMA240816P9000
- 0.19
- 0.000.00%
ADMA Biologics Newsroom
What's in Store for ADMA Biologics (ADMA) in Q2 Earnings?
Revenues Not Telling The Story For ADMA Biologics, Inc. (NASDAQ:ADMA) After Shares Rise 26%
ADMA Biologics, Inc. (NASDAQ:ADMA) shares have continued their recent momentum with a 26% gain in the last month alone. The annual gain comes to 250% following the latest surge, making investors
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday.Shares of Leslie's, Inc. (NASDAQ:LESL) fell sharply in today's pre-market trading after the
Zacks.com Featured Highlights Include ADMA Biologics, American Superconductor, Biote, Lincoln Educational Services and Corcept Therapeutics
Institutional Investors Control 77% of ADMA Biologics, Inc. (NASDAQ:ADMA) and Were Rewarded Last Week After Stock Increased 15%
Key Insights Significantly high institutional ownership implies ADMA Biologics' stock price is sensitive to their trading actions 50% of the business is held by the top 19 shareholders Recent
Express News | ADMA Biologics Inc : Raymond James Raises Target Price to $16 From $10
We Might See A Profit From ADMA Biologics, Inc. (NASDAQ:ADMA) Soon
How Is The Market Feeling About ADMA Biologics?
ADMA Biologics's (NYSE:ADMA) short percent of float has fallen 23.1% since its last report. The company recently reported that it has 7.27 million shares sold short, which is 3.23% of all regular
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year?
ADMA Biologics Is Maintained at Overweight by Cantor Fitzgerald
ADMA Biologics Is Maintained at Overweight by Cantor
ADMA Biologics Price Target Raised to $15.00/Share From $10.00 by Cantor Fitzgerald
ADMA Biologics Price Target Raised to $15.00/Share From $10.00 by Cantor
Adma Biologics (ADMA) Is on the Move, Here's Why the Trend Could Be Sustainable
Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Buy Rating, Raises Target Price to $15
Cantor Fitzgerald analyst Kristen Kluska maintains $ADMA Biologics(ADMA.US)$ with a buy rating, and adjusts the target price from $10 to $15.According to TipRanks data, the analyst has a success
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
Implied Volatility Surging for ADMA Biologics (ADMA) Stock Options
The 4.9% Return This Week Takes ADMA Biologics' (NASDAQ:ADMA) Shareholders Three-year Gains to 645%
For us, stock picking is in large part the hunt for the truly magnificent stocks. But when you hold the right stock for the right time period, the rewards can be truly huge. Take, for example, the A
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
6 analysts have shared their evaluations of ADMA Biologics (NASDAQ:ADMA) during the recent three months, expressing a mix of bullish and bearish perspectives.The following table provides a quick overv
ADMA Biologics Is Maintained at Buy by Mizuho
ADMA Biologics Is Maintained at Buy by Mizuho